February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA Monday Tuesday Programming: IBC s 17th International Process & Analytical Assay Validation IBC s 8th International Outsourcing Manufacturing of Biopharmaceuticals IBC s 7th International Technology Transfer for Biopharmaceuticals Biopharmaceutical Raw Materials throughout the Product Lifecycle IBC s 9th Annual Viral Safety for Biologicals Wednesday Friday Programming: IBC s 28th International Antibody Development & Production IBC s 3rd Annual Recombinant Protein & Complex Biologic Development & Production IBC s 2nd Annual Analytical Technologies for Biotherapeutic Development Biosimilars and Biobetters Development and Global Experiences www.ibclifesciences.com/bdpweek See how your company can participate and reach the target market that will benefit your bottom line.
What is this Event all about? Biopharmaceutical Development & Production Week welcomes over 550 attendees who come to learn from the most respected industry scientists, engineers and executives for five full days of programming. As a sponsor or exhibitor, this means that you will have access to a captivated, enthusiastic audience for an entire week. IBC s 17th International Process & Analytical Assay Validation As the industry moves towards a risk-based, lifecycle approach to process and analytical assay validation to ensure continuous monitoring of the product pre- and post-approval, industry experts will come together at this event to explore the varying interpretation and implementation of FDA s new Process Validation Guidance and discuss how companies can successfully integrate the new guidance into their existing validation programs. IBC s 8th International Outsourcing Manufacturing of Biopharmaceuticals This conference brings to the forefront the critical elements of agent-sponsor relations, including sponsor s oversight of agency s quality and performance, having good control over supply chain networks, as well as developing a smooth and successful technology transfer to ensure the ultimate goal of consistent high quality products from CMO partners. IBC s 7th International Technology Transfer for Biopharmaceuticals Given the stringent regulatory oversight, shorter schedules and higher expectations, this event will bring together scientists and engineers in technology transfer, process development, manufacturing science, pilot plants, CMOs and raw material vendors to discuss strategies to minimize risk, enhance productivity and ensure efficient and smooth technology transfers. Biopharmaceutical Raw Materials throughout the Product Lifecycle New to the market, this conference offers strategies to identify raw material variability as a potential problem before it happens, solutions for controlling and mitigating the risk of raw material variability in process development and manufacturing and techniques for working with raw material suppliers to ensure raw materials meet quality/safety standards. IBC s 28th International Antibody Development & Production Regarded as one of the industry s most comprehensive, this event attracts attendees from all phases of development and manufacturing representing companies of all sizes to collectively discuss the challenges, share opportunities and review the latest developments in the industry. IBC s 3rd Annual Recombinant Protein & Complex Biologic Development & Production This event is quickly becoming one of the best events for process development scientists, engineers and technical specialists who are focused on developing novel and next-generation molecules to connect and share experiences and lessons learned. IBC s 2nd Annual Analytical Technologies for Biotherapeutic Development This is the new place for companies to develop and integrate the latest analytical technologies, optimize quality at every stage of process and product development, and share ideas and data from the latest case studies. Biosimilars and Biobetters Development and Global Experiences Drawing on the experience of biosimilar developers from across the globe, this conference will evaluate development strategies, the current success of biosimilars, as well as upcoming pipelines and strategies for biosimilars and biobetters. IBC s 9th Annual Viral Safety for Biologicals With up-to-date strategies for detection and prevention efforts for laboratories and facilities, various new methods for virus spike preparation and the implementation of platform processes/ modular viral clearance, as well as updates from several regulators representing the FDA and the European regulatory bodies, this event will attract forward thinking people from across the industry. 2
February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA Good topics, good people, discussions on the point! - J. Friedle, Managing, Atoll GmbH I greatly enjoyed the conference, in particular the quality of the case studies that were presented. The speakers were very open to sharing ideas and lessons learned from real-world projects. The information discussed was quite relevant to my own work. I would highly recommend these types of conferences. - M. Pujols, Manufacturing, MedImmune, LLC Creative and innovative approaches to solving problems M. Wallace, Upstream Process Development, Merrimack Pharmaceuticals Inc IBC continues to put together a well organized series of conferences that cover the key topics and areas of interest across the biotech industry. They provide an excellent forum to bring together leading scientists and companies to exchange ideas and create networking contacts. - W.D. Taylor,, Business Development, Pfenex Great conference with many valuable topics covered M. Kane, Associate, Process Statistics, HGSI Niche Programming that is attractive to scientists, engineers & executives from across the Biopharmaceutical field. As the first Biopharmaceutical event of 2012, involvement with these events will lead to an earlier boost to sales. The Bottom Line: 20% International Attendance will help spread your branding further. Strategic Location The Southern California area is home to top biopharmaceutical companies. 3
February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA Audience Demographics By Job Title Overall By Geography 15% Vice 6% Other Academic Associate/Specialist/ Executive 9% C-Level / Europe 11% Pacific 2% Asia 5% North America 82% Head /Lead 7% 19% Engineer / 35% Mon-Tue Programming By Job Title Wed-Fri Programming By Job Title Other 5% 21% Academic 2% Associate / Specialist / Executive 7% C-Level / 4% 2 Head /Lead 7% 11% Other Vice 6% Academic 4% Associate / Specialist / Executive 11% C-Level / 17% Head /Lead 7% Engineer / 28% Engineer / 38% Confirmed Exhibitors for 2012 3M Purification Aragen Bioscience Avid Bioservices, Inc BD Biosciences Bio-Rad Laboratories Boehringer Ingelheim GmbH Catalent Pharma Solutions CMC Biologics Cook Pharmica DSM Biologics FrieslandCampina DOMO Fujifilm Diosynth Biotechnologies GenScript Gyros Irvine Scientific KBI Biopharma Lancaster Laboratories Life Technologies Pall Life Sciences PERCIVIA ProMetic BioSciences Rentschler Biotechnologie Repligen SANDOZ Sartorius-Stedim Sharp Corporation Spectrum Laboratories, Inc Thermo Scientific Wuxi Apptec 4
A Partial List of Attendees by Company and Job Title Abbott BioResearch Center Research Associate II Senior Acceleron Pharmaceuticals Validation Engineer Adnexus, a Bristol Myers Squibb R&D Comp Staff Aeras TB Vaccine Foundation Senior Agensys Inc Biochemist Alder BioPharmaceuticals Consultant Development Associate III Pharm Ops DSP Principal Senior Alexion Pharmaceuticals Inc Development II Alkermes Inc Staff Allergan Inc Chemistry Project Engineer Senior Alnylam Biotherapeutics Senior Ambrx, Inc. Functional Head American Society for Quality Senior Member - Quality Practitioner Amgen, Inc. Executive Principle Scientific Senior Associate Senior Engineer Amunix, Inc. Chief Executive Officer Asahi Glass Company Limited Deputy Production AutekBio (Beijing), Inc., Manufacture Business Avecia OligoMedicines Process Development Group Leader BASF Corporation Research Becton Dickinson Bend Research Inc Research Chemical Engineer Biogen Idec, Inc. Principal Investigator BioMarin Pharmaceutical, Inc. Principal Senior Process II BioProcess Technology Consultants Senior Consultant Bioproduction Group Co- and Principal Bio-Rad Laboratories, Process R&D Applications Group Boehringer Ingelheim Pharma GmbH & Co. Corporate Senior Vice Project Management Group Head of Process Science Project Leader Project Bristol Myers Squibb Senior Research Centocor Research & Development, Inc. Associate CMC ICOS Biologics, Inc. Associate Development Development Associate II Manufacturing Associate Principal Development Process Tech Specialist QA Associate III Senior Cook Pharmica LLC CSL Limited Bioanalytical Science Principal Purification Dendreon Corporation Senior Engineer Senior Eli Lilly & Company Associate Consultant Biologist Associate Senior Consultant Engineer Biochemist, Bioprocess Operations, Bioassay Development Research Senior Emergent BioSolutions Inc, Process Development Principal Scientific Enobia FDA Finesse Solutions LLC Validation Freeslate Inc Product GE Healthcare Applications Specialist Chromatogrphy Media Specialist of Key Accounts Field Applications Specialist Modality Leader Chromatography Product Specialist Research Engineer Senior 5
Genentech, Inc. Associate Associate Engineer Manufacturing Technical Specialist Postdoctoral Research Fellow Principal Engineer Research Associate and Senior Senior Engineer Genzyme Corporation Process Engineer III Staff II Geron Corporation GlaxoSmithKline Principal GT Life Sciences, Inc. Senior, R&D Gyros AB Hospira Adelaide Pty Ltd Biologics Research & Development Hospira, Inc. Validation, Global Biologics R&D Human Genome Sciences, Inc. Bioprocess Engineer Senior ImClone Systems Inc Associate Research ImmunoGen, Inc. Executive Process Engineer Invitrogen Corporation Senior Technology Area Irvine Scientific Chief Operating Officer Group Support Specialist A Partial List of Attendees by Company and Job Title Laureate Pharma, Inc. LG Life Sciences Life Technologies General Process Science Fellow Light Sciences Oncology Inc Drug Manufacturing Lonza Biologics PLC Global Principal MedImmune, Inc. Associate Merck & Co., Inc. Distinguished Senior Investigator Research Fellow R&D Research Microbiologist Senior Senior Investigator Staff Biochemical Engineer Micromet AG Project Management Millennium Pharmaceuticals Millipore Corporation of Purification Research III Momenta Pharmaceuticals Associate Morphotek Inc MSD Biologics Head of Process and Analytical Sciences Technical Project Leader Nectar Lifesciences Ltd CEO NGM Biopharmacuticals NNE Pharmaplan Senior Consultant Novartis QA Head, BioPharmaceutical Operations Novozymes AS Pall Corporation Application Senior Technical Pfizer, Inc. Associate Research Fellow and Principal Principal Engineer II Senior PolyBatics Ltd Chief Executive Officer Regeneron Pharmaceuticals Inc Process Development Engineer Staff Engineer Repligen Corporation Bio Process Development Revalesio Corporation Operations Specialist Process Engineer Operations Mfg Richmond Chemical Corporation Roche Diagnostics GmbH SAFC Pharma Sandoz Biopharmaceuticals Menges Head Sanofi Aventis SA Head of Biotherapeutics Sartorius Stedim Biotech Group Schering Plough Research Institute Development Fellow Seattle Genetics Inc Associate Principal Research Associate II Research Associate III Senior Shire Human Genetic Therapies Associate Principal Development Engineer Process Validation Senior Development Specialist Sutro Biopharma, Inc. Symphogen A/S Takeda Pharmaceutical Company Limited Associate Principal Researcher Therapure Biopharma & Head Trubion Pharmaceuticals Senior UGA Synageva BioPharma University of California, San Diego Professor US Department of Health & Human Services Project Officer US Food & Drug Administration Consumer Safety Officer VLST Corporation Wyeth Pharmaceuticals Principal Engineer II III Xencor, Inc. and Chief Executive Officer XOMA (US) LLC Senior Yooyoung Pharmaceutical Researcher Senior Research ZymoGenetics Inc Associate 6
February 27 March 2, 2012 Hilton San Diego Bayfront San Diego, CA With competition for the market s attention stronger than ever, we understand that your company needs to extend reach beyond your booth in order to build relationships and connect with attendees. Biopharmaceutical Development & Production Week sponsorships offer a variety of ways for you to raise your company s awareness in this valued market both pre-show and on-site. High Visibility Speaking Sponsorships: Technology Workshop Sponsor: Includes a 30 minute presentation within a set schedule of timeslots. Strategic Discussion Group Sponsor: As a discussion group sponsor, you ll have the opportunity to choose a topic, moderator, and panelists (subject to producer s approval and with their assistance) for a 60 minute breakout session with the goal being an engaging, interactive session. Session Sponsor: As a session sponsor, you ll have the opportunity to choose a session, moderator, and a 30 minute presentation (preferably an end-user and subject to the producer s approval) within your sponsored session. Luncheon Presentation Sponsor: Sponsor a plated sit-down lunch one day of the conference & conduct a 45-minute presentation during. All food & beverage included in this package. Networking Cocktail Reception: As the sponsor of the Networking Cocktail Reception, your company will receive a 30 minute presentation built into the conference session (preferably an end-user and subject to the producer s approval). Your company will be highlighted on signage throughout the Exhibit Hall for the Sponsored Reception. Branding Sponsorships: Internet Café Registration Area Padfolio Refreshment Break Espresso Café Host Hotel Room Keys Aisle Signs Badge/Lanyard Tote Bag Event Guide Tote Bag Insert Water Bottles Online Materials Password Additional Sponsorship Opportunities/Exhibit Upgrades Platinum, Gold, Silver, Bronze Sponsorships: upgrade to an event sponsorship which includes logo attribution, additional registrations, etc. Focus Group Sponsor: Bring together a small selective group of Key delegates to discuss issues and share ideas/solutions. Literature Sponsorship: Includes distribution of marketing materials from Resource Center & signage. Webinar: Connect with key prospects, showcase your thought leadership and receive qualified leads. 7